Omega-3 Fatty Acids (DHA/EPA) لـ Mild Cognitive Impairment (MCI)
BResearch suggests 66.7% of RCTs in MCI populations reported positive cognitive outcomes with omega-3 supplementation. DHA appears to be the most critical component for brain-specific cognitive support.
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'braincited.com';
const params = 'ingredient\u003Domega\u002D3\u002Ddha\u002Depa\u0026condition\u003Dmild\u002Dcognitive\u002Dimpairment';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
B
الخلاصة
Research suggests 66.7% of RCTs in MCI populations reported positive cognitive outcomes with omega-3 supplementation. DHA appears to be the most critical component for brain-specific cognitive support.
Key Study Findings
Systematic Review
n=3582
Natural Products in Alzheimer's Disease: A Systematic Review of Clinical Trials and Underlying Molecular Mechanisms.
Dose: None
مقابل: Placebo or control
Outcome: Cognitive function in AD and MCI patients
التأثير: None
None
المجتمع المدروس: AD and MCI patients aged 50-90 (31 clinical trials)
Randomized Controlled Trial
n=73
12 weeks
Single-blind
Comparing the Efficacy of Combined Intralesional Triamcinolone Acetonide With Topical Calcipotriol Versus Intralesional Triamcinolone Acetonide …
Dose: IL triamcinolone every 4 weeks + calcipotriol twice daily
مقابل: IL triamcinolone acetonide alone
Outcome: Hair density (regrowth scale)
التأثير: None
0.018 (scalp subgroup at wk12)
المجتمع المدروس: Patients with scalp and beard alopecia areata (179 patches)
Review
Effects of Dietary Interventions on Cognitive Outcomes.
Dose: None
مقابل: None
Outcome: Cognitive outcomes (memory, executive function)
التأثير: None
None
المجتمع المدروس: Aging adults with cognitive impairment (review)
Review
Nutrition, cognition and chronic kidney disease: A comprehensive review of interactions and interventions.
Dose: None
مقابل: None
Outcome: None
التأثير: None
None
المجتمع المدروس: None
Other
Milk Fat Globules: 2024 Updates.
Dose: None
مقابل: None
Outcome: Inflammatory markers
التأثير: None
None
المجتمع المدروس: None
Systematic Review
The Role of Omega-3 Fatty Acid Supplementation in Slowing Cognitive Decline Among Elderly Patients With …
Dose: None
مقابل: None
Outcome: Cognitive function
التأثير: None
None
المجتمع المدروس: Alzheimer's disease patients
Key Statistics
18
الدراسات
3200
المشاركون
↑
Positive
B
التقييم
Referenced Papers
European journal of …
2025
8 اقتباسات
Nutrients
2025
6 اقتباسات
Natural Products in Alzheimer's Disease: A Systematic Review of Clinical Trials and Underlying Molecular Mechanisms.
Systematic Review
International journal of …
2025
2 اقتباسات
Journal of cutaneous …
2025
European journal of …
2024
16 اقتباسات
Lasers in medical …
2024
10 اقتباسات
Healthcare (Basel, Switzerland)
2024
9 اقتباسات
Newborn (Clarksville, Md.)
2024
9 اقتباسات
Cureus
2024
8 اقتباسات
Journal of cosmetic …
2024
1 اقتباسات
American family physician
2024
Current opinion in …
2023
58 اقتباسات
Nutrition reviews
2023
18 اقتباسات
Archives of dermatological …
2023
3 اقتباسات
Vitamin Supplementation and Dementia: A Systematic Review.
Systematic Review
Nutrients
2022
76 اقتباسات
Brain, behavior, and …
2022
64 اقتباسات
European journal of …
2022
63 اقتباسات
The American journal …
2022
18 اقتباسات
Journal of Ayub …
2022
4 اقتباسات
The effects of twenty-one nutrients and phytonutrients on cognitive function: A narrative review.
Review
Journal of clinical …
2021
38 اقتباسات
Antioxidants (Basel, Switzerland)
2021
33 اقتباسات
Diet enriched in omega-3 fatty acids alleviates olfactory system deficits in APOE4 transgenic mice.
Other
The European journal …
2021
4 اقتباسات
The Senior care …
2021
2 اقتباسات
Nutrients
2020
72 اقتباسات
Journal of cutaneous …
2020
21 اقتباسات
Psychiatrike = Psychiatriki
2020
15 اقتباسات
Journal of Alzheimer's …
2020
14 اقتباسات
FASEB journal : …
2020
8 اقتباسات
Omega-3 fatty acids and cognitive decline: a systematic review.
Systematic Review
Nutricion hospitalaria
2019
40 اقتباسات
Alzheimer's research & …
2019
29 اقتباسات
The journal of …
2018
24 اقتباسات
Journal of Alzheimer's …
2018
12 اقتباسات
FASEB journal : …
2017
41 اقتباسات
Actas espanolas de …
2017
22 اقتباسات
FASEB journal : …
2017
21 اقتباسات
Current Alzheimer research
2017
7 اقتباسات
Journal of Alzheimer's …
2016
128 اقتباسات
NeuroImage
2016
118 اقتباسات
FP essentials
2016
11 اقتباسات
Individually modifiable risk factors to ameliorate cognitive aging: a systematic review and meta-analysis.
Meta-Analysis
Climacteric : the …
2015
92 اقتباسات
Journal of Alzheimer's …
2015
8 اقتباسات
European journal of …
2014
204 اقتباسات
Nutrition (Burbank, Los …
2014
74 اقتباسات
Acta clinica Belgica
2014
44 اقتباسات
Nutricion hospitalaria
2014
17 اقتباسات
Advances in nutrition …
2013
155 اقتباسات
Journal of Alzheimer's …
2012
257 اقتباسات
Journal of Alzheimer's …
2012
137 اقتباسات
Alzheimer disease and …
2011
52 اقتباسات
Molecular neurobiology
2010
145 اقتباسات
Journal of Alzheimer's …
2010
110 اقتباسات
Journal of Alzheimer's …
2010
55 اقتباسات
Women's health (London, …
2010
48 اقتباسات
JAMA
2009
304 اقتباسات
Progress in neuro-psychopharmacology …
2008
388 اقتباسات
Alternative medicine review …
2008
Alternative medicine review …
2007
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
الجرعات الشائعة
- general:
- 1,000-2,000 mg combined DHA/EPA per day
- cognitivesupport:
- 1,000-1,700 mg/day (optimal dose-response curve)
الحد الأعلى: 3,000 mg/day combined DHA/EPA (FDA GRAS)
الجرعات المدروسة في الأبحاث
| الجرعة | المدة | التأثير | ن |
|---|---|---|---|
| None | -- | Mixed | 3582 |
| IL triamcinolone every 4 weeks + calcipotriol twice daily | 12 weeks | Positive | 73 |
| None | -- | Positive | -- |
| None | -- | Mixed | -- |
| None | -- | Positive | -- |
| None | -- | Mixed | -- |
| Vitamin D3 vs triamcinolone acetonide | 12 weeks | Positive | 40 |
| None | -- | Positive | -- |
أفضل وقت للتناول: With meals containing fat for better absorption
Safety & Side Effects
الآثار الجانبية المُبلّغ عنها
- ⚠ Fishy aftertaste or burping
- ⚠ Mild gastrointestinal discomfort
- ⚠ Potential increased bleeding time at very high doses
- ⚠ May lower blood pressure slightly
التفاعلات المعروفة
- ● Anticoagulants and antiplatelet drugs (may increase bleeding risk at high doses)
- ● Blood pressure medications (additive hypotensive effect)
- ● Orlistat (may reduce omega-3 absorption)
الحد الأقصى المسموح به: 3,000 mg/day combined DHA/EPA (FDA GRAS)
استشر مقدم الرعاية الصحية دائماً قبل البدء بأي مكمل غذائي.
Frequently Asked Questions
Does Omega-3 Fatty Acids (DHA/EPA) help with Mild Cognitive Impairment (MCI)?
Based on 18 studies with 3,200 participants, there is moderate evidence from clinical studies that Omega-3 Fatty Acids (DHA/EPA) may support Mild Cognitive Impairment (MCI) management. Our evidence grade is B (Good Evidence).
How much Omega-3 Fatty Acids (DHA/EPA) should I take for Mild Cognitive Impairment (MCI)?
Studies have used various dosages. A commonly studied range is 1,000-2,000 mg combined DHA/EPA per day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Omega-3 Fatty Acids (DHA/EPA)?
Reported side effects may include Fishy aftertaste or burping, Mild gastrointestinal discomfort, Potential increased bleeding time at very high doses, May lower blood pressure slightly. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Omega-3 Fatty Acids (DHA/EPA) and Mild Cognitive Impairment (MCI)?
We rate the evidence as Grade B (Good Evidence). This rating is based on 18 peer-reviewed studies with 3,200 total participants. The overall direction of effect is positive.
Related Evidence
مكونات أخرى لـ Mild Cognitive Impairment (MCI)
Omega-3 Fatty Acids (DHA/EPA) لحالات أخرى
إخلاء مسؤولية FDA: لم تُقيَّم هذه البيانات من قبل إدارة الغذاء والدواء (FDA). لا تهدف المنتجات والمعلومات الواردة في هذا الموقع إلى تشخيص أو علاج أو شفاء أو الوقاية من أي مرض. تستند تقييمات الأدلة المعروضة إلى تحليلنا للأبحاث المحكّمة المنشورة ولا تُشكّل نصيحة طبية. استشر مقدم الرعاية الصحية دائماً قبل البدء بأي نظام مكملات.